Saturday 17 October 2026
Export LKFT’s income statement to Excel — free account
Lakefront Biotherapeutics - Sponsored ADR
LKFT Healthcare Biotechnology
Lakefront Biotherapeutics - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 321.9% from fiscal 2024. In the quarter to June 2026, revenue fell 95.4%, EPS grew 198.9% and free cash flow grew 18.2%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
29.90
0.03
−0.10%
Follow LKFT
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
3,391.99 | 3,418.07 | 3,987.74 | 4,313.50 | 5,564.33 | 5,895.94 | 6,474.53 | 1,524.43 | 1,301.21 | 1,084.26 |
Receivables |
58.74 | 94.53 | 71.31 | 70.12 | 151.63 | 197.07 | 85.07 | 35.21 | 44.93 | 22.00 |
Inventory |
25.45 | 55.39 | 80.07 | 55.76 | 24.34 | 0.00 | 0.00 | 0.00 | 0.32 | 0.33 |
Other current assets |
7.92 | 45.63 | 40.29 | 24.56 | 11.77 | 40.39 | 10.23 | 9.74 | 7.24 | 8.01 |
Total current assets |
3,484.10 | 3,613.62 | 4,179.40 | 4,463.95 | 5,752.06 | 6,133.41 | 6,569.84 | 1,569.37 | 1,353.70 | 1,114.60 |
Property, Plant, Equpment (Net) |
91.26 | 132.99 | 136.72 | 162.52 | 162.69 | 118.09 | 73.98 | 27.32 | 18.87 | 16.56 |
Long-Term Investments |
76.92 | 273.90 | — | 5.32 | 1.14 | 12.35 | 14.61 | 8.05 | 3.61 | 3.16 |
Long-term receivables |
197.33 | 189.58 | 152.88 | 126.37 | 150.47 | 184.62 | 104.62 | 86.74 | 72.34 | 59.96 |
Goodwill and Intangible Assets (Total) |
0.96 | 254.16 | 213.71 | 227.75 | 71.11 | 77.18 | 27.92 | 4.29 | 2.82 | 1.13 |
Long Term Assets (Tax, Deferred) |
0.22 | 1.60 | 1.22 | 1.44 | 4.77 | 5.11 | 4.71 | 2.97 | 2.24 | 2.17 |
Long-term assets (Other) |
3.35 | 9.42 | 32.08 | 6.09 | 2.93 | 12.96 | 15.78 | 9.35 | 3.91 | 4.40 |
Total non-current assets |
370.04 | 861.64 | 536.61 | 524.17 | 391.97 | 397.96 | 227.00 | 130.67 | 100.18 | 84.22 |
Total Assets |
3,854.14 | 4,475.26 | 4,716.01 | 4,988.11 | 6,144.03 | 6,531.36 | 6,796.84 | 1,700.05 | 1,453.88 | 1,198.82 |
Accounts Payable |
118.40 | 106.99 | 146.33 | 156.64 | 162.58 | 196.92 | 160.65 | 81.40 | 53.26 | 34.60 |
Accrued Expenses |
— | — | — | — | — | — | — | — | 1.31 | 0.69 |
Current Part of Capital Lease |
— | 3.76 | — | 7.60 | — | — | 6.53 | — | 0.01 | 0.06 |
Current Part of Taxes to Pay |
1.08 | 0.27 | 0.06 | 1.08 | 2.11 | 1.43 | 2.28 | 1.39 | 0.98 | 1.13 |
Current Revenue (Deferred) |
0.04 | 251.56 | 277.36 | 385.23 | 496.74 | 506.22 | 464.01 | 176.92 | 138.51 | 78.38 |
Other current liabilities |
51.48 | — | 34.68 | 405.32 | 0.24 | 13.80 | 6.94 | 173.56 | 149.40 | 75.79 |
Total current liabilities |
172.95 | 362.59 | 463.47 | 550.55 | 670.20 | 725.67 | 640.41 | 259.71 | 194.07 | 114.86 |
Long Term Debt (Total) |
5.87 | — | 5.35 | 15.48 | 22.73 | 28.40 | 22.47 | — | — | 0.01 |
Non-current Revenue (Deferred) |
— | 907.75 | 1,159.35 | 1,710.62 | 2,300.94 | 2,702.65 | 2,905.62 | — | 110.03 | 237.68 |
Pension and Post-Retirement Liabilities |
— | 2.27 | 2.48 | 5.84 | 13.84 | 17.13 | 9.25 | 4.45 | 4.05 | 3.90 |
Long Term Tax Liability (Deferred) |
— | 22.36 | 25.55 | 21.23 | (4.55) | (4.94) | (4.49) | (3.45) | (2.41) | (2.11) |
Non-current Liabilities (Other) |
14.26 | 36.60 | 34.17 | 22.98 | 8.44 | 9.25 | 2,904.54 | 1.86 | 1.88 | 2.80 |
Total non-current liabilities |
20.12 | 977.89 | 1,226.90 | 1,776.15 | 2,346.47 | 2,755.34 | 2,935.70 | 6.31 | 115.96 | 244.39 |
Total liabilities |
193.07 | 1,340.48 | 1,690.37 | 2,326.69 | 3,016.67 | 3,481.02 | 3,576.11 | 266.02 | 310.03 | 359.24 |
Additional Paid In Capital |
3,096.64 | 2,961.70 | 2,962.25 | 2,882.18 | 3,230.33 | 3,116.01 | 3,028.01 | 1,509.06 | 1,122.42 | 718.33 |
Common Stock (Net) |
332.56 | 318.07 | 318.13 | 309.34 | 345.55 | 332.77 | 321.76 | 279.35 | 263.83 | 247.80 |
Retained Earnings |
238.25 | (145.33) | (247.06) | (523.31) | (434.44) | (382.33) | (122.33) | (351.68) | (238.99) | (124.24) |
Shareholders Equity (Other) |
(6.38) | 0.34 | (7.67) | (6.79) | (14.08) | (16.10) | (6.70) | (2.71) | (3.41) | (2.31) |
Common Equity (Total) |
3,661.06 | 3,134.78 | 3,025.64 | 2,661.42 | 3,127.36 | 3,050.35 | 3,220.74 | 1,434.03 | 1,143.85 | 839.58 |
Shareholders Equity (Total) |
3,661.06 | 3,134.78 | 3,025.64 | 2,661.42 | 3,127.36 | 3,050.35 | 3,220.74 | 1,434.03 | 1,143.84 | 839.58 |
Shareholders Equity and Liabilities (Total) |
3,854.14 | 4,475.26 | 4,716.01 | 4,988.11 | 6,144.03 | 6,531.36 | 6,796.84 | 1,700.05 | 1,453.88 | 1,198.82 |
Shares (Common) |
65.90 | 65.90 | 65.90 | 65.84 | 65.55 | 65.41 | 64.67 | 54.47 | 50.94 | 46.26 |
Shareholders Equity (Tangible) |
3,660.10 | 2,880.62 | 2,811.93 | 2,433.67 | 3,056.25 | 2,973.17 | 3,192.82 | 1,429.74 | 1,141.02 | 838.45 |
Net Debt |
(3,386.12) | (3,418.07) | (3,982.38) | (4,298.02) | (5,541.60) | (5,867.55) | (6,452.06) | (1,524.43) | (1,301.21) | (1,084.25) |
Total Debt |
5.87 | — | 5.35 | 15.48 | 22.73 | 28.40 | 22.47 | — | 0.00 | 0.01 |
In millions of $ except per-share values · columns are period end dates